PIOLAX, Inc. Share Price

Equities

5988

JP3780400002

Auto, Truck & Motorcycle Parts

Market Closed - Japan Exchange 11:30:00 02/05/2024 am IST 5-day change 1st Jan Change
2,646 JPY -0.41% Intraday chart for PIOLAX, Inc. +0.68% +13.56%

Financials

Sales 2024 * 64.75B 422M 35.27B Sales 2025 * 65.75B 428M 35.82B Capitalization 90.08B 587M 49.07B
Net income 2024 * 4.25B 27.7M 2.32B Net income 2025 * 4.88B 31.8M 2.66B EV / Sales 2024 * 1.05 x
Net cash position 2024 * 22.39B 146M 12.2B Net cash position 2025 * 18.87B 123M 10.28B EV / Sales 2025 * 1.08 x
P/E ratio 2024 *
21.2 x
P/E ratio 2025 *
18.2 x
Employees 2,824
Yield 2024 *
4.93%
Yield 2025 *
5.5%
Free-Float 65.52%
More Fundamentals * Assessed data
Dynamic Chart
PIOLAX, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Tranche Update on PIOLAX, Inc.'s Equity Buyback Plan announced on November 9, 2021. CI
PIOLAX, Inc.'s Equity Buyback announced on November 9, 2021, has expired with 874,000 shares, representing 2.52% for ¥1,499.96 million. CI
Tranche Update on PIOLAX, Inc.'s Equity Buyback Plan announced on November 9, 2021. CI
PIOLAX, Inc. announces an Equity Buyback for 1,250,000 shares, representing 3.45% for ?1,500 million. CI
PIOLAX, Inc. authorizes a Buyback Plan. CI
PIOLAX, Inc. Announces Dividend for the Year Ended March 31, 2021, Scheduled to Start Dividend Payment June 23, 2021 and Provides Dividend Guidance for the Fiscal Full Year 2022 CI
PIOLAX, Inc. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2019; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2020; Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2020 CI
Tranche Update on PIOLAX, Inc.'s Equity Buyback Plan announced on November 6, 2019. CI
PIOLAX, Inc.'s Equity Buyback announced on November 6, 2019 has expired with 914,000 shares for ¥1,999.85 million. CI
Tranche Update on PIOLAX, Inc.'s Equity Buyback Plan announced on November 6, 2019. CI
PIOLAX, Inc. announces an Equity Buyback for 1,500,000 shares, representing 4.04% for ¥2,000 million. CI
PIOLAX, Inc. authorizes a Buyback Plan. CI
Piolax Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2019; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2020 CI
Piolax, Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half of Fiscal Year 2020 and Year Ending March 31, 2020; Provides Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2020 CI
More news
1 day-0.41%
1 week+0.68%
Current month-2.54%
1 month-0.64%
3 months+5.84%
6 months+20.88%
Current year+13.56%
More quotes
1 week
2 570.00
Extreme 2570
2 683.00
1 month
2 547.00
Extreme 2547
2 719.00
Current year
2 296.00
Extreme 2296
2 807.00
1 year
1 867.00
Extreme 1867
2 807.00
3 years
1 348.00
Extreme 1348
2 807.00
5 years
1 202.00
Extreme 1202
2 807.00
10 years
1 033.32
Extreme 1033.323
3 545.00
More quotes
Managers TitleAgeSince
President 66 01/81/01
Director/Board Member - -
Director/Board Member 60 01/87/01
Members of the board TitleAgeSince
President 66 01/81/01
Director/Board Member 67 01/07/01
Director/Board Member - -
More insiders
Date Price Change Volume
02/24/02 2,646 -0.41% 74 800
01/24/01 2,657 -0.97% 76,400
30/24/30 2,683 +3.03% 119,400
26/24/26 2,604 +0.12% 93,900
25/24/25 2,601 -1.70% 52,200

Delayed Quote Japan Exchange, May 02, 2024 at 11:30 am IST

More quotes
PIOLAX, INC. is a Japan-based company principally engaged in the manufacture and sale of automotive related products. The Company operates in two business segments. Automotive Related Business segment is mainly involved in the manufacture and sale of precision springs, industrial fasteners, as well as small unit parts that combine resin and metal to the automobile industry. Medical Equipment Business segment is involved in the manufacture and sale of interventional radiology (IVR), endoscopic treatment, and orthopedic treatment equipment to medical institutions.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2,646 JPY
Average target price
2,365 JPY
Spread / Average Target
-10.62%
Consensus